Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Proud Evoked Health ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8% 0.8%   Bankruptcy risk   5.8% 15.2% 11.1% 15.3% 10.7% 14.8% 15.8% 15.5%   Credit score (0-100)   41 14 22 12 22 13 12 13   Credit rating   BBB BB BB BB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 -0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   835 6.5 322 287 616 506 0.0 0.0   EBITDA   365 -132 -199 -127 299 -62.2 0.0 0.0   EBIT   365 -132 -211 -162 247 -115 0.0 0.0   Pre-tax profit (PTP)   364.5 -116.8 -178.4 -164.4 247.8 -135.1 0.0 0.0   Net earnings   284.3 -101.2 -145.9 -129.3 190.5 -116.5 0.0 0.0   Pre-tax profit without non-rec. items   365 -117 -178 -164 248 -135 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 41.8 110 57.9 5.4 0.0 0.0   Shareholders equity total   294 193 47.2 -82.0 108 -8.1 -48.1 -48.1   Interest-bearing liabilities   0.0 0.0 15.0 97.0 16.9 0.0 48.1 48.1   Balance sheet total (assets)   512 380 367 259 229 138 0.0 0.0   Net Debt   -217 -4.4 -197 97.0 12.3 -11.3 48.1 48.1     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   835 6.5 322 287 616 506 0.0 0.0   Gross profit growth   0.0% -99.2% 4,823.3% -11.0% 115.1% -18.0% -100.0% 0.0%   Employees   0 0 0 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   512 380 367 259 229 138 0 0   Balance sheet change%   0.0% -25.9% -3.3% -29.5% -11.5% -39.9% -100.0% 0.0%   Added value   364.9 -132.5 -199.1 -127.2 281.7 -62.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 30 33 -105 -105 -5 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 -2.0 -3.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   43.7% -2,025.8% -65.5% -56.7% 40.0% -22.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   71.3% -25.5% -43.6% -45.9% 87.3% -60.5% 0.0% 0.0%   ROI %   124.0% -46.7% -127.5% -203.8% 223.8% -180.8% 0.0% 0.0%   ROE %   96.6% -41.5% -121.4% -84.5% 103.8% -94.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   57.5% 50.9% 12.9% -24.1% 47.3% -5.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -59.5% 3.3% 98.8% -76.3% 4.1% 18.2% 0.0% 0.0%   Gearing %   0.0% 0.0% 31.8% -118.2% 15.6% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 206.2% 3.8% 1.8% 257.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.4 2.0 1.0 0.4 1.3 0.8 0.0 0.0   Current Ratio   2.4 2.0 1.0 0.4 1.3 0.8 0.0 0.0   Cash and cash equivalent   217.2 4.4 211.7 0.0 4.6 11.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   294.3 193.1 5.5 -201.5 37.6 -26.5 -24.1 -24.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 -127 282 -62 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 -127 299 -62 0 0   EBIT / employee   0 0 0 -162 247 -115 0 0   Net earnings / employee   0 0 0 -129 190 -117 0 0